Skip to Content

'
Elizabeth A. Lano, M.D.

Present Title & Affiliation

N/A

Office Address

The University of Texas MD Anderson Cancer Center
1515 Holcombe Boulevard
Unit Number: 1473
Houston, TX 77030
Room Number: FCT15.6044
Phone: (713) 792-8635
Fax: (713) 745-1151

Education & Training

Degree-Granting Education

1989 The University of Texas Medical School at Houston, Houston, TX, MD, Medicine
1985 Davidson College, Davidson, NC, BS, Chemistry

Postgraduate Training

1995-1996 Clinical Fellowship, Body Imaging, The University of Texas Medical School at Houston, Houston, TX, Dr. Nabil Maklad
1991-1995 Clinical Residency, Diagnostic Radiology, The University of Texas Health Science Center at Houston, Houston, TX, Dr. Sandra A. Oldham
1990-1991 Clinical Residency, Internal Medicine, Baylor College of Medicine, Houston, TX, Dr. Edward Lynch
1989-1990 Clinical Internship, Internal Medicine, Baylor College of Medicine, Houston, TX, Dr. Irving Schweppe

Board Certifications

1995 American Board of Radiology

Experience/Service

Academic Appointments

Associate Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005-2012

Administrative Appointments/Responsibilities

Co-Director of Medical Student Education, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2000-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Wang H, Cleary KR, Staerkel GA, Charnsangavej C, Lano EA, Ho L, Lenzi R, Abbruzzese JL, Wolff RA. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol. 26(21):3496-3502, 7/2008. PMID: 18640930.
Other Articles
1. Jimenez C, Cabanillas ME, Santarpia L, Jonasch E, Kyle KL, Lano EA, Matin SF, Nunez RF, Perrier ND, Phan A, Rich TA, Shah B, Williams MD, Waguespack SG. Use of the tyrosine kinase inhibitor sunitinib in a patient with Von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other Von Hippel-Lindau disease-related tumors. J Clin Endocrinol Metab 94(2):386-391, 2/2009. e-Pub 11/18/2008. PMID: 19017755.

Last updated: 5/30/2014